GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EyeGene Inc (XKRX:185490) » Definitions » Cyclically Adjusted Revenue per Share

EyeGene (XKRX:185490) Cyclically Adjusted Revenue per Share : ₩175.49 (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is EyeGene Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

EyeGene's adjusted revenue per share for the three months ended in Mar. 2025 was ₩30.331. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₩175.49 for the trailing ten years ended in Mar. 2025.

During the past 12 months, EyeGene's average Cyclically Adjusted Revenue Growth Rate was 2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2025-06-02), EyeGene's current stock price is ₩3290.00. EyeGene's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₩175.49. EyeGene's Cyclically Adjusted PS Ratio of today is 18.75.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of EyeGene was 25.93. The lowest was 14.73. And the median was 17.40.


EyeGene Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for EyeGene's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EyeGene Cyclically Adjusted Revenue per Share Chart

EyeGene Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 170.78

EyeGene Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 171.81 169.33 169.80 170.78 175.49

Competitive Comparison of EyeGene's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, EyeGene's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EyeGene's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EyeGene's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where EyeGene's Cyclically Adjusted PS Ratio falls into.


;
;

EyeGene Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, EyeGene's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=30.331/122.5900*122.5900
=30.331

Current CPI (Mar. 2025) = 122.5900.

EyeGene Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 2.445 100.051 2.996
201509 2.102 100.111 2.574
201512 1.882 100.220 2.302
201603 19.719 100.561 24.039
201606 0.293 100.791 0.356
201609 0.187 101.461 0.226
201612 0.186 101.561 0.225
201703 0.187 102.851 0.223
201706 0.186 102.611 0.222
201709 15.180 103.491 17.982
201712 7.200 102.991 8.570
201803 0.673 104.101 0.793
201806 15.583 104.130 18.345
201809 158.659 105.651 184.098
201812 51.965 104.351 61.048
201903 62.367 104.491 73.170
201906 60.183 104.881 70.345
201909 103.616 105.200 120.744
201912 65.166 105.121 75.995
202003 59.556 105.354 69.299
202006 42.827 105.112 49.948
202009 50.895 106.198 58.751
202012 50.702 105.765 58.767
202103 53.092 107.357 60.625
202106 58.290 107.579 66.424
202109 104.625 108.759 117.930
202112 33.791 109.676 37.770
202203 49.664 111.848 54.434
202206 61.862 114.072 66.481
202209 75.541 114.715 80.727
202212 59.707 115.179 63.549
202303 36.188 116.507 38.077
202306 27.547 117.182 28.818
202309 25.286 118.964 26.057
202312 54.791 118.837 56.521
202403 19.360 120.123 19.758
202406 20.849 120.007 21.298
202409 35.466 120.861 35.973
202412 48.505 121.135 49.088
202503 30.331 122.590 30.331

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


EyeGene  (XKRX:185490) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

EyeGene's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3290.00/175.49
=18.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of EyeGene was 25.93. The lowest was 14.73. And the median was 17.40.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


EyeGene Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of EyeGene's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


EyeGene Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EyeGene Inc (XKRX:185490) » Definitions » Cyclically Adjusted Revenue per Share
Traded in Other Exchanges
N/A
Address
Gangseo-gu, Seoul 401, B-dong 910 Gayang-dong, Seoul, KOR, 07528
EyeGene Inc is a South Korea based bio-venture company. It researches and develops biopharmaceuticals. Its products include EG-Mirotin, EG-HPV, EGVac systems. It provides drugs for the treatment of age-related degenerative diseases. Its products target diabetic retinopathy.

EyeGene Headlines

No Headlines